US 5,334,391 AGranted

Intracellularly cleavable compounds

AssigneeAnergen, Inc.

InventorsBrian R. Clark, Bishwajit Nag

Life of this patent

Estimating the term…

Intracellularly cleavable derivatives of toxic compounds including antibiotics are described.

Dependent claims

A liposome having a compound anchored in the liposome bilayer said compound having the formula:

Dependencies are inferred from the claim text.

C07K 17/06
Peptides being immobilised on, or in, an organic carrier: attached to the carrier via a bridging agent
A61K 9/1271
Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant: non-conventional liposomes,…
A61K 47/543
The modifying agent being an organic compound: lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
A61K 47/6425
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is…: the…

From the US filing history. Foreign family members aren’t listed.

Loading patent…